| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/24/2013 | CN103054843A Application of altenusin compound and pharmaceutically acceptable salt thereof in preparation of medicaments for treating FXR-mediated diseases |
| 04/24/2013 | CN103054809A Curcumin-particle-containing sustained-release microsphere with high medicament loading capacity as well as preparation method and application thereof |
| 04/24/2013 | CN103054807A Curcumin micro-powder composition for intramuscular or hypodermic injection as well as preparation method and application thereof |
| 04/24/2013 | CN103054805A Preparation method and application of injection for needle-free injection |
| 04/24/2013 | CN103054041A Preparation process of okra extractive dry powder |
| 04/24/2013 | CN103054038A Preparation method of bamboo leaf flavonoid extract for reducing blood sugar activity |
| 04/24/2013 | CN103054028A Aloe-dietary fibre convenient granules |
| 04/24/2013 | CN102604797B Beautifying and detoxifying wine and its preparation method |
| 04/24/2013 | CN102552806B Fat-burning dredging particles and preparation method thereof |
| 04/24/2013 | CN102550756B Compound health-care tea containing vine tea and preparation method thereof |
| 04/24/2013 | CN102526315B Preparation method of extracts of effective fractions of lychee seeds |
| 04/24/2013 | CN102397460B Preparation method of Kang'erxin capsule |
| 04/24/2013 | CN102397399B Application of traditional Chinese medicinal composition in preparation of medicament for controlling diabetes complications |
| 04/24/2013 | CN102380049B Decoction for treating diabetic peripheral neuropathy |
| 04/24/2013 | CN102362862B Double-layer sustained-release tablet for reducing blood fat coordinately |
| 04/24/2013 | CN102309575B Application of medicinal composition in preparing medicament for treating diabetic complication |
| 04/24/2013 | CN102309464B Folic acid tablet and preparation method thereof |
| 04/24/2013 | CN102240293B Application of echinocystic acid in preparing medicament preventing and treating cardiovascular diseases |
| 04/24/2013 | CN102167753B Preparation method of oat beta-glucan |
| 04/24/2013 | CN102145041B Pharmaceutical composition with function of treating polycystic ovary syndrome |
| 04/24/2013 | CN102112122B Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof |
| 04/24/2013 | CN102100904B Reduced glutathione percutaneous absorption preparation and preparation method thereof |
| 04/24/2013 | CN102058652B Traditional Chinese medicinal extract for treating diabetes mellitus, medicinal composition thereof and preparation method thereof |
| 04/24/2013 | CN102058563B Double-controlled release gliclazide sustained-release capsules and preparation method thereof |
| 04/24/2013 | CN102008598B Blood fat-lowering and liver-protecting composite as well as preparation prepared thereby and preparation method of preparation |
| 04/24/2013 | CN101934036B Method for preparing medicament for treating diabetes mellitus |
| 04/24/2013 | CN101909640B Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly |
| 04/24/2013 | CN101848720B 糖尿病治疗剂 Therapeutic agents for diabetes |
| 04/24/2013 | CN101716180B Combined medicament for supplementing zinc and calcium and preparation method thereof |
| 04/24/2013 | CN101602680B Naphthyl ethylamine derivative and preparation method thereof and application of naphthyl ethylamine derivative in preparing weight-reducing medicament |
| 04/24/2013 | CN101555284B Truncated-type human ciliary nerve nutrition factor active segment and fusion protein thereof |
| 04/24/2013 | CN101503408B 8-(3-amino-piperidin-1-yl)-xanthines |
| 04/24/2013 | CN101501049B Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
| 04/24/2013 | CN101474339B Pharmaceutical composition for reducing blood sugar |
| 04/24/2013 | CN101474307B Pharmaceutical composition for reducing blood sugar and blood fat |
| 04/24/2013 | CN101474302B Pharmaceutical composition for reducing blood sugar |
| 04/24/2013 | CN101300346B Novel biological substance nesfatin and its related substances and uses thereof |
| 04/23/2013 | US8426588 Phenylalanine derivatives |
| 04/23/2013 | US8426468 Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism |
| 04/23/2013 | US8426363 Method for reducing a level of LDL-cholesterol by an antibody that specifically binds to PCSK9 |
| 04/23/2013 | US8426362 Compositions comprising SIA for the treatment of diabetes |
| 04/23/2013 | CA2752530C Delivery of active agents using a chocolate vehicle |
| 04/23/2013 | CA2552311C Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity |
| 04/23/2013 | CA2410563C Methods for preventing strokes by inducing tolerance to e-selectin |
| 04/18/2013 | WO2013055910A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 04/18/2013 | WO2013055385A2 Methods of treating age related disorders |
| 04/18/2013 | WO2013054338A1 2-thio-imidazole derivatives as tgr5 modulators |
| 04/18/2013 | WO2013054002A1 Prevention and diagnosis of visceral fat |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096113 Heterocyclic compounds and methods of use thereof |
| 04/18/2013 | US20130096073 Casein Derived Peptides And Uses Thereof |
| 04/18/2013 | US20130095190 Oral liquid vitamin and supplement compositions |
| 04/18/2013 | US20130095189 Composition and method of phytonutrients for metabolic programming effects |
| 04/18/2013 | US20130095089 Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| 04/18/2013 | CA2852055A1 Dietary supplements with rapid buccal dissolution |
| 04/18/2013 | CA2852027A1 Recombinant human naglu protein and uses thereof |
| 04/17/2013 | EP2581441A1 Method of treating autoimmune disease with mesenchymal stem cells |
| 04/17/2013 | EP2581389A1 Fusion protein of exendin-4 and its analog, preparation method and use thereof |
| 04/17/2013 | EP2581373A1 Benzo- or pyrido-imidazole derivative |
| 04/17/2013 | EP2581094A2 Composition for inhibiting hyperlipidemia and obesity by inhibiting intestinal absorption of cholesterol |
| 04/17/2013 | EP2581092A1 Lipid metabolism-improving agent |
| 04/17/2013 | EP2580225A1 Crystalline form of benzylbenzene sglt2 inhibitor |
| 04/17/2013 | EP2580208A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
| 04/17/2013 | EP2579945A2 Inhibiting striated muscle activator of rho signaling (stars) to improve glycemic control |
| 04/17/2013 | EP2579898A1 Peptide-carrying nanoparticles |
| 04/17/2013 | EP2579876A2 Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes |
| 04/17/2013 | EP2579867A1 Triheptanoin diet for adult polyglucosan body disease (apbd) treatment |
| 04/17/2013 | CN1854300B Recombinant plasmid containing PON gene and its use |
| 04/17/2013 | CN1816346B Abuse resistant amphetamine compounds |
| 04/17/2013 | CN1747739B The use of lupin conglutin in preparing medicine for the treatment of type ii diabetes, food additive or food |
| 04/17/2013 | CN103052633A Amids Substituted Indazole Derivativees As Ploy(adp-ribose)polymerase Inhibitors |
| 04/17/2013 | CN103052403A Treating Disorders Associated With IL-20 Receptor-mediated Signaling Pathway By Blocking IL-20 Receptor Activity |
| 04/17/2013 | CN103052397A Adenovirus AD36 E4ORF1 protein for prevention and treatment of non-alcoholic fatty liver disease |
| 04/17/2013 | CN103052393A Treatment of diabetes with pancreatic endocrine precursor cells |
| 04/17/2013 | CN103052391A Pyrroloquinoline quinone gel |
| 04/17/2013 | CN103045631A Preparation method for oral hypoglycemic recombinant human proinsulin |
| 04/17/2013 | CN103045442A Geshen health wine and production method thereof |
| 04/17/2013 | CN103044571A Iron dextran bulk drug and preparation method thereof |
| 04/17/2013 | CN103044540A GLP-1 analogue, and preparation method and application of GLP-1 analogue |
| 04/17/2013 | CN103044477A Trimethyl silicon substituted benzopyran compound and application thereof |
| 04/17/2013 | CN103044414A Benzothiazole derivative, preparation method and application thereof |
| 04/17/2013 | CN103044409A Puerarin derivative or pharmaceutically acceptable salt and application thereof |
| 04/17/2013 | CN103044392A Preparation method of high-efficient DPP (dipeptidyl peptidase)-IV inhibitor |
| 04/17/2013 | CN103044391A High-efficient DPP (dipeptidyl peptidase)-IV inhibitor |
| 04/17/2013 | CN103044322A (3E, 5E)-3,5-bipiperidyl-4-ketone analogue and preparation method and application thereof |
| 04/17/2013 | CN103044310A Indoline-3-acetic acid derivative and preparation method thereof as well as application of derivative in medicine |
| 04/17/2013 | CN103044250A Carboxylic acid derivatives compound and preparation method and application thereof |
| 04/17/2013 | CN103044227A (2E, 6E)-2,6-bis(benzylidene)cyclohexanone analogue and preparation method and application thereof |
| 04/17/2013 | CN103044224A Penta-1,4-diene-3-ketone analogue and preparation method and application thereof |
| 04/17/2013 | CN103041391A Biguanide and probucol composition medicament for treating nonalcoholic fatty liver disease |
| 04/17/2013 | CN103041390A Melbine and ezetimibe combined composition medicament for treating nonalcoholic fatty liver disease |
| 04/17/2013 | CN103041361A Medicament for treating three-high disease (high cholesterol, high blood pressure, high blood sugar) and preparation method thereof |
| 04/17/2013 | CN103041288A Chinese medicinal composition for treating diabetic fatty liver and preparation process thereof |
| 04/17/2013 | CN103041282A Traditional Chinese medicine for treating deficiency of spleen and kidney and preparation method of medicine |
| 04/17/2013 | CN103041216A Medicament for treating diabetes |
| 04/17/2013 | CN103041197A Traditional Chinese medicine composition for treating hypertension |
| 04/17/2013 | CN103041177A Chinese medicament for treating diabetic foot |
| 04/17/2013 | CN103041122A Medicinal composition for improving sugar tolerance of impaired glucose tolerance (IGT) patient |
| 04/17/2013 | CN103041118A Composition with effects of reducing blood sugar and reducing blood lipid |
| 04/17/2013 | CN103041112A Traditional Chinese medicine for treating simple obesity fatty liver |